Flow Cytometry The Flow Cytometry Core provides services to HCCC members from all 6 research programs conducting both laboratory and clinical cancer research. The mission of the Flow Cytometry Facility is to serve HCCC investigators by providing state-of-the-art Flow Cytometry Services including: 1) High speed sorting 2) Multi-parameter analysis 3) High efficiency purification of cell subsets 4) Training and assisting investigators with software programs available for interpretation and analysis of data 5) Individual training of the investigators and their laboratory personnel in the use of the bench-top instruments, which are subsequently available to them on a 24/7 basis. The Flow Cytometry Facility is in a constant process of developing new technology and services as requested and/or needed by HCCC investigators. Consultation is readily available to all investigators by the Director, the Technical Director and other support personnel in the facility. In 2009, 72 HCCC members with peer-reviewed research funding used the Flow Cytometry Facility.

Public Health Relevance

The ability to analyze the expression of molecules on the surface and within individual cells, and to sort those cells based on expression of those molecules, is an essential tool for many cancer investigators. The cancer research supported by this shared resource provides state-of-the-art facilities and outstanding expertise in Flow Cytometry and cell sorting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-14
Application #
8640099
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
14
Fiscal Year
2014
Total Cost
$111,261
Indirect Cost
$28,740
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Jethava, Yogesh S; Barlogie, Bart; Tricot, Guido J (2017) Drug Combinations with Transplantation for Myeloma. N Engl J Med 377:91-2
Gilbertson-White, Stephanie; Bohr, Nicole; Wickersham, Karen E (2017) Conducting Biobehavioral Research in Patients With Advanced Cancer: Recruitment Challenges and Solutions. Biol Res Nurs 19:481-490
Meyerholz, David K; Ofori-Amanfo, Georgina K; Leidinger, Mariah R et al. (2017) Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models. J Histochem Cytochem 65:607-618
Ebbert, Jon O; Little, Melissa A; Klesges, Robert C et al. (2017) Step Care treatment for smoking cessation. Health Educ Res 32:1-11
Sfeir, J G; Drake, M T; LaPlant, B R et al. (2017) Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia. Blood Cancer J 7:e526
Mohiuddin, I; Allen, B G (2017) A Single-Institution Experience in Treating Thymic Carcinoma. Int J Radiat Oncol Biol Phys 98:229
Miller, Benjamin J (2017) CORR Insights®: Is It Appropriate to Treat Sarcoma Metastases With Intramedullary Nailing? Clin Orthop Relat Res 475:218-220
Huang, Jianguo; Chen, Mark; Whitley, Melodi Javid et al. (2017) Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma. Nat Commun 8:15999
Salem, Aliasger K (2017) Recent Advances in Musculoskeletal Tissue Regeneration. AAPS J 19:1253-1254
Hoffman, Richard M; Volk, Robert J; Wolf, Andrew M D (2017) Making the grade: The newest US Preventive Services Task Force prostate cancer screening recommendation. Cancer 123:3875-3878

Showing the most recent 10 out of 831 publications